Evidence map›Paper›PMID 28623185›Full record

ArticleJMIR research protocols2017

A Web-Based Data Collection Platform for Multisite Randomized Behavioral Intervention Trials: Development, Key Software Features, and Results of a User Survey.

Riddhi A Modi, Michael J Mugavero, Rivet K Amico, Jeanne Keruly, Evelyn Byrd Quinlivan, Heidi M Crane, Alfredo Guzman, Anne Zinski, Solange Montue, Katya Roytburd and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01900236 (Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01900236 nacompletednot on this map

Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2013 to 2018Enrolled371ConditionsHIVArmsBased on behavioral motivational interviewing (MI) technique
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Riddhi A ModiUniversity of Alabama at Birmingham, Birmingham, AL, United States.ORCID http://orcid.org/0000-0002-0047-1035
Michael J MugaveroUniversity of Alabama at Birmingham, Birmingham, AL, United States.ORCID http://orcid.org/0000-0001-6916-6701
Rivet K AmicoUniversity of Michigan, Ann Arbor, MI, United States.ORCID http://orcid.org/0000-0002-4458-6934
Jeanne KerulyJohn Hopkins University, Baltimore, MD, United States.ORCID http://orcid.org/0000-0002-8489-435X
Evelyn Byrd QuinlivanUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-1213-8707
Heidi M CraneUniversity of Washington, Seattle, WA, United States.ORCID http://orcid.org/0000-0002-3308-7005
Alfredo GuzmanUniversity of Alabama at Birmingham, Birmingham, AL, United States.ORCID http://orcid.org/0000-0003-2145-6720
Anne ZinskiUniversity of Alabama at Birmingham, Birmingham, AL, United States.ORCID http://orcid.org/0000-0003-0414-248X
Solange MontueJohn Hopkins University, Baltimore, MD, United States.ORCID http://orcid.org/0000-0003-2357-6005
Katya RoytburdUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0003-0630-9087
Anna ChurchUniversity of Washington, Seattle, WA, United States.ORCID http://orcid.org/0000-0003-2379-1979
James H WilligUniversity of Alabama at Birmingham, Birmingham, AL, United States.ORCID http://orcid.org/0000-0001-7462-368X
University of Alabama at Birmingham · USUniversity of North Carolina at Chapel Hill · USJohns Hopkins University · USUniversity of Michigan · USUniversity of Washington · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIVR01AI103661 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MUGAVERO, MICHAEL J · 2012 to 2016
$4.0M
NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI103661
6 · The paper itself

Abstract

backgroundMeticulous tracking of study data must begin early in the study recruitment phase and must account for regulatory compliance, minimize missing data, and provide high information integrity and/or reduction of errors. In behavioral intervention trials, participants typically complete several study procedures at different time points. Among HIV-infected patients, behavioral interventions can favorably affect health outcomes. In order to empower newly diagnosed HIV positive individuals to learn skills to enhance retention in HIV care, we developed the behavioral health intervention Integrating ENGagement and Adherence Goals upon Entry (iENGAGE) funded by the National Institute of Allergy and Infectious Diseases (NIAID), where we deployed an in-clinic behavioral health intervention in 4 urban HIV outpatient clinics in the United States. To scale our intervention strategy homogenously across sites, we developed software that would function as a behavioral sciences research platform.

objectiveThis manuscript aimed to: (1) describe the design and implementation of a Web-based software application to facilitate deployment of a multisite behavioral science intervention; and (2) report on results of a survey to capture end-user perspectives of the impact of this platform on the conduct of a behavioral intervention trial.

methodsIn order to support the implementation of the NIAID-funded trial iENGAGE, we developed software to deploy a 4-site behavioral intervention for new clinic patients with HIV/AIDS. We integrated the study coordinator into the informatics team to participate in the software development process. Here, we report the key software features and the results of the 25-item survey to evaluate user perspectives on research and intervention activities specific to the iENGAGE trial (N=13).

resultsThe key features addressed are study enrollment, participant randomization, real-time data collection, facilitation of longitudinal workflow, reporting, and reusability. We found 100% user agreement (13/13) that participation in the database design and/or testing phase made it easier to understand user roles and responsibilities and recommended participation of research teams in developing databases for future studies. Users acknowledged ease of use, color flags, longitudinal work flow, and data storage in one location as the most useful features of the software platform and issues related to saving participant forms, security restrictions, and worklist layout as least useful features.

conclusionsThe successful development of the iENGAGE behavioral science research platform validated an approach of early and continuous involvement of the study team in design development. In addition, we recommend post-hoc collection of data from users as this led to important insights on how to enhance future software and inform standard clinical practices.

trial registrationClinicaltrials.gov NCT01900236; (https://clinicaltrials.gov/ct2/show/NCT01900236 (Archived by WebCite at http://www.webcitation.org/6qAa8ld7v).

Indexed as

behavioral researchHIViENGAGEsoftware designsurveyuser perspectiveWeb application

Identifiers

PMID28623185
PMCPMC5493783
OpenAlexW2625294123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.